Cancer, Bronchogenic Carcinoma

Medications for Bronchogenic Carcinoma

Other titles: Cancer, Bronchogenic Carcinoma

About Bronchogenic Carcinoma: Bronchogenic carcinoma is a malignant neoplasm of the lung due to the epithelium of the bronchus or bronchiole.

The following set of medications are used in the treatment of this illness, or in some way associated with.

Drug title	Rx / OTC	Pregnancy	CSA	Alcohol	Reviews	Rating
Adriamycin	Rx	D	N		Add inspection	0.0
Generic name: doxorubicin systemic Drug course: antibiotics/antineoplastics For consumers: dosage, interactions, side effects For specialists: Prescribing Information

cimetidineAway Tag	Rx/OTC	B	N	X	Add inspection	0.0
Generic name: cimetidine systemic Drug course: H 2 antagonists For consumers: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph, Prescribing Information Off-label: Yes

doxorubicin	Rx	D	N		Add inspection	0.0
Generic name: doxorubicin systemic Brand name: Adriamycin Drug course: antibiotics/antineoplastics For consumers: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph, Prescribing Information

Rx	Prescription-only
OTC	On The Counter
Rx/OTC	Prescription or Over The Counter
Away Tag	This drug Might Not Be approved by the FDA for the treatment of this ailment.

Pregnancy Category
A	Adequate and well-controlled studies have failed to demonstrate a risk to the embryo within the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B	Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women.
C	Animal reproduction studies have demonstrated a negative effect on the fetus and there are no sufficient and well-controlled studies in humans, but possible benefits may warrant use in pregnant women despite potential risks.
D	there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant use in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved in use in pregnant women obviously outweigh potential rewards.
N	FDA has not classified the drug.

Controlled Substances Act (CSA) Program
N	Is not subject to the Controlled Substances Act.
Inch	features a higher potential for abuse. Has no currently accepted medical use in treatment in the United States. There`s just a lack of accepted safety for use under medical supervision.
Two	features a higher potential for abuse. Features a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Abuse may cause severe physical or psychological dependency.
3	features a possibility for abuse less than those in schedules 1 and 2 2. Features a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4	features a minimal potential for abuse in accordance with those in program 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence.
5	features a minimal potential for abuse in accordance with those in program 4. Features a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence.

Infection
X	Interacts with Medication.

Always ask your physician to make sure the information displayed on this page applies to your circumstances.